Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination therapy used in fertility treatments, particularly for assisted reproductive technologies like in vitro fertilization (IVF). The combination consists of three components with distinct functions: 1. **Growth hormone**: Enhances ovarian response to stimulation 2. **Human pituitary follicle-stimulating hormone (FSH)**: Stimulates the development of ovarian follicles 3. **GnRH antagonist**: Prevents premature ovulation by blocking gonadotropin-releasing hormone receptors This combination is typically used in controlled ovarian stimulation protocols for patients undergoing IVF, particularly those who may be poor responders to standard stimulation protocols.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on growth hormone + human pituitary follicle-stimulating hormone + GnRH antagonist.